Summary
Boston Scientific Corporation (BSX) has filed a Current Report on Form 8-K on December 10, 2009, to retroactively revise specific sections of its 2008 Annual Report on Form 10-K. These revisions are to align the 2008 financial reporting with a change in the company's reportable segments, which became effective on January 1, 2009, as part of an international restructuring aimed at enhancing direct sales focus. Investors should note that this filing does not introduce new financial events or developments occurring after February 27, 2009. Instead, it serves to update historical segment reporting for the 2008 fiscal year to reflect the new organizational structure. The updated information pertains to disclosures regarding international operations, net sales by segment, goodwill allocation, and segment reporting details within the 2008 10-K. Investors are encouraged to review this 8-K in conjunction with BSX's 2008 10-K and subsequent 2009 quarterly reports (10-Qs) for a comprehensive understanding of the company's performance and reporting structure.
Key Highlights
- 1Boston Scientific (BSX) is retroactively revising its 2008 Form 10-K to reflect a change in reportable segments.
- 2The change in reportable segments was implemented effective January 1, 2009, as part of an international restructuring.
- 3The restructuring aims to provide a more direct sales focus in the marketplace.
- 4Revisions affect discussions on international operations, net sales by segment, goodwill allocation, and segment reporting in the 2008 10-K.
- 5This 8-K filing does not disclose events or developments after February 27, 2009.
- 6The information in this filing supersedes the corresponding portions of the original 2008 10-K.
- 7Investors should consult subsequent 2009 10-Q filings for the most current financial information and segment performance.